We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · June 25, 2022

Adverse Cardiovascular Events and Mortality in Men During Testosterone Treatment

The Lancet Healthy Longevity


Additional Info

The Lancet Healthy Longevity
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
LANHL 2022 Jun 01;3(6)e381-e393, J Hudson, M Cruickshank, R Quinton, et al

Further Reading